Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NBIO - Nascent Biotech receives U.S. patent for brain cancer therapy

NBIO - Nascent Biotech receives U.S. patent for brain cancer therapy

Nascent Biotech

  • Nascent Biotech ( OTCQB:NBIO ) said on Tuesday that the United States Patent and Trademark Office had granted patent for claims related to the its lead candidate Pritumumab to treat brain cancer.
  • The patent application, which is titled, "Kits and containers for treating Vimentin expressing Tumors" provides broad protection for Pritumumab and the storage conditions related to its use in clinical applications.

For further details see:

Nascent Biotech receives U.S. patent for brain cancer therapy
Stock Information
Company Name: Nascent Biotech
Stock Symbol: NBIO
Market: OTC
Website: nascentbiotech.com
Menu
NBIO NBIO Quote NBIO Short NBIO News NBIO Articles NBIO Message Board
Get NBIO Alerts

News, Short Squeeze, Breakout and More Instantly...